LongevAI
AI-Powered Longevity & Biological Age Analysis Platform
Project Purpose
LongevAI is an experimental biomedical technology project designed to analyze an individual’s biological age, aging speed, and longevity potential, independent of chronological age.
Rather than focusing on disease treatment after it occurs, LongevAI aims to
understand, predict, and slow down the aging process before it becomes irreversible.
The Problem
- Modern healthcare systems are largely:
- Disease-oriented rather than preventive
- Reactive instead of predictive
- Fragmented in terms of personal health data
- Individuals may know their age, but they rarely understand
how fast their body is aging and why.
The Solution
- LongevAI brings together fragmented biological and lifestyle data and interprets it using artificial intelligence to create a personal longevity profile.
- The platform transforms raw data into:
- Biological age estimation
- Aging speed index
- Longevity risk and protection scores
How It Works
- With user consent, LongevAI analyzes multiple data layers, including:
- Blood tests & biological markers
- Sleep quality & recovery patterns
- Stress indicators & cognitive load
- Physical activity levels
- Nutrition habits
- (Future phase) genetic predisposition data
- These inputs are processed through AI-based models to generate actionable longevity insights.
Why It’s Different
- Longevity research is still underdeveloped in many regions
- Preventive aging analytics are rarely accessible to individuals
- Health data is often scattered and underutilized
- LongevAI positions itself at the intersection of artificial intelligence, preventive healthcare, and longevity science, aiming to contribute to the next generation of health technologies.
Project Status
- Research & concept development phase
- MVP planning in progress
- Open to clinical and academic collaborations
- Open to strategic partnerships & investment discussions
Vision
“People know how old they are.
LongevAI helps them understand how they are aging — and how to change it.”
Project Status
- Research & concept development phase
- MVP planning in progress
- Open to clinical and academic collaborations
- Open to strategic partnerships & investment discussions
Target Audience
- Health-tech and biotech investors
- Research institutions & clinics
- Longevity-focused professionals
- Organizations interested in preventive health solutions
